BSAC Spring Conference & AGM

Effective Antimicrobial Management: The What, Why & How

16-17 May 2024

QEII Conference Centre London & online

Professor Alasdair MacGowan

Alasdair MacGowan is Consultant in Infection at North Bristol NHS Trust and Professor of Antimicrobial Therapeutics at the University of Bristol. He has led a mixed NHS academic research group in the area of antimicrobial chemotherapy for over twenty five years, and provides medical input into the National Antibiotic Assay Reference Laboratory at Southmead Hospital. He has a research interest in antibacterial pharmacokinetics/dynamics, rapid diagnostics, antimicrobial resistance in the community, and patient and public involvement in infection research. He holds several Programme Grants related to antibacterial drug development from the EU’s IMI, has a Research for Patient Benefit Grant on antibiotic optimisation to prevent emergence of resistance, and is microbiological lead on a joint MRC (UK) China project studying antimicrobial resistance in rural China. At present, active grants total >£15m. He is a former President of the British Society for Antimicrobial Chemotherapy (BSAC), is a member of the BSAC Standing Committee on Antimicrobial Susceptibility Testing, and is UK representative on European CDC Expert Committee EUCAST. He is a Fellow of the Royal College of Physicians (Edinburgh), Royal College of Pathologists, and was a first title bearer of Fellowship of ESCMID.